Reference
Sekikawa M, et al. Safety and efficacy of amrubicin with primary prophylactic pegfilgrastim as second-line chemotherapy in patients with small cell lung cancer. Thoracic Cancer 14 : 3475-3482, No. 35, Dec 2023. Available from: URL: https://dx.doi.org/10.1111/1759-7714.15140
Rights and permissions
About this article
Cite this article
Amrubicin/pegfilgrastim. Reactions Weekly 2004, 43 (2024). https://doi.org/10.1007/s40278-024-56682-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-024-56682-1